DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 30, 2018, Jeffry R. Keyes, the Chief Financial Officer of Digirad Corporation (the “Company”), notified the Company that he will resign from all positions with the Company, effective April 10, 2018. Matthew G. Molchan, the Company’s Chief Executive Officer, will assume the additional role of Interim Chief Financial Officer until a successor is appointed. As Interim Chief Financial Officer, Mr. Molchan will also become the Company’s principal financial officer, effective April 10, 2018. The Company is conducting a search for a Chief Financial Officer and will name a successor at the completion of the search.
Mr. Molchan, age 51,became the Company’s President, Chief Executive Officer and member of the Board of Directors on July 1, 2013. In connection with the Company's investment in Perma-Fix Medical, S.A. ("Perma-Fix Medical"), a publicly traded company listed on the NewConnect market of the Warsaw Stock Exchange and a majority-owned subsidiary of Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), Mr. Molchan was appointed to the Supervisory Board of Perma-Fix Medical in December 2015. From February 2013 to July 2013, Mr. Molchan held the position of President, Digirad Corporation. He was previously President, Digirad Imaging Solutions, Inc. from January 2012 to June 2013. Prior to that, he was Chief Operating Officer of Digirad Ultrascan Solutions from May 2007 to January 2012. He joined Digirad Ultrascan Solutions upon the acquisition of Ultrascan, Inc. by us in May 2007. Prior to joining the Company, Mr.Molchan was the Chief Financial Officer for Ultrascan since he joined Ultrascan in 2003. Prior to Ultrascan, Mr.Molchan held various executive level business development, finance and operations positions at Somera, Inc. and Equifax, Inc. Mr.Molchan earned a B.S. degree in Economics from the United States Air Force Academy and an M.B.A. in finance from the University of Southern California.
There are no arrangements or understandings between Mr. Molchan and any other persons to which he was selected as Interim Chief Financial Officer. There are also no family relationships between Mr. Molchan and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed to Item 404(a) of Regulation S-K.
About DIGIRAD CORPORATION (NASDAQ:DRAD)
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers.
